Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE) - Concepedia

Concepedia

Publication | Open Access

Long-term efficacy and safety of α1 proteinase inhibitor treatment for emphysema caused by severe α1 antitrypsin deficiency: an open-label extension trial (RAPID-OLE)

DOI Full Paper Access

191

Citations

20

References

2016

Year

Noel G. McElvaney, Jonathan Burdon, Mark Holmes, Allan R. Glanville, Peter Wark, Philip J. Thompson, Paul Hernandez, J Chlumský, Helmut Teschler, Joachim H. Ficker,

The Lancet Respiratory Medicine

Open-label Extension TrialLong-term EfficacyImmunologyPulmonary PharmacologyMedicine

References

	Year	Citations

Page 1